Engineers Gate Manager’s Vir Biotechnology VIR Stock Holding History

Engineers Gate Manager’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Sell	128,427 -121,964	-49%	-$1.16M	0.02%	926
2026 Q1	$2.24M	Buy	+250,391	New	+$2M	0.03%	674
2025 Q3	–	Sell	-56,730	Closed	-$286K	–	2570
2025 Q2	$286K	Sell	56,730 -76,900	-58%	-$412K	﹤0.01%	1753
2025 Q1	$866K	Buy	+133,630	New	+$1.19M	0.01%	1147
2024 Q3	–	Sell	-48,294	Closed	-$430K	–	2433
2024 Q2	$430K	Buy	48,294 +2,238	+5%	+$21.5K	0.01%	1286
2024 Q1	$467K	Sell	46,056 -30,516	-40%	-$311K	0.01%	1225
2023 Q4	$770K	Buy	76,572 +59,173	+340%	+$541K	0.02%	939
2023 Q3	$163K	Buy	+17,399	New	+$248K	0.01%	1534
2023 Q2	–	Sell	-62,440	Closed	-$1.45M	–	2058
2023 Q1	$1.45M	Buy	62,440 +43,642	+232%	+$1.12M	0.06%	428
2022 Q4	$476K	Sell	18,798 -41,428	-69%	-$1.02M	0.03%	927
2022 Q3	$1.16M	Buy	60,226 +17,962	+42%	+$457K	0.07%	378
2022 Q2	$1.08M	Sell	42,264 -6,471	-13%	-$151K	0.04%	667
2022 Q1	$1.25M	Buy	+48,735	New	+$1.45M	0.05%	530
2021 Q4	–	Sell	-33,864	Closed	-$1.47M	–	2310
2021 Q3	$1.47M	Buy	+33,864	New	+$1.47M	0.08%	326

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Engineers Gate Manager's VIR Position: Q2 2026 in Review

Engineers Gate Manager reduced its Vir Biotechnology (VIR) stake by 49% in Q2 2026, selling an estimated $1.16M and leaving 128,427 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #926.

Engineers Gate Manager first reported a position in VIR in Q3 2021 and has held it in 14 quarters since. The position peaked at $2.24M in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Engineers Gate Manager held 128,427 shares of Vir Biotechnology worth $1.31M as of Q2 2026.
Engineers Gate Manager sold 121,964 Vir Biotechnology shares in Q2 2026, an estimated $1.16M.
Vir Biotechnology made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #926 holding.
Engineers Gate Manager first reported a position in Vir Biotechnology in Q3 2021 and has held it in 14 quarters since.
Engineers Gate Manager's Vir Biotechnology position peaked at $2.24M in Q1 2026.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.